Measles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy.

Citation:
Newman LP, Njoroge A, Ben-Youssef L, Merkel M, Gatuguta A, Ton Q, Elizabeth Maleche Obimbo, Dalton Wamalwa, Lohman-Payne B, Richardson BA, Ruth Nduati, Farquhar C. "Measles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy." Pediatr. Infect. Dis. J.. 2014.

Abstract:

This paper describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.

Notes:

n/a

UoN Websites Search